Navigation Links
SanBio Announces The Completion Of Enrollment Of Its Clinical Trial Of Cell Therapy For Chronic Stroke Deficits
Date:9/4/2013

MOUNTAIN VIEW, Calif., Sept. 4, 2013 /PRNewswire/ -- SanBio Inc. today announced the successful completion of enrollment of patients in its Phase 1/2 clinical trial testing the safety and efficacy of a novel allogeneic cell therapy product, SB623, in patients suffering from chronic deficits resulting from previous stroke injuries. A total of 18 patients have been successfully administered SB623. The trial is being conducted at Stanford University and the University of Pittsburgh. No safety concerns have been attributed to the cell therapy product. For details regarding this clinical trial, please refer to www.clinicaltrials.gov/ct2/show/NCT01287936.

SB623 is derived from bone marrow and has shown safety and efficacy in rodent models of chronic stroke.  "Complete enrollment of this clinical trial is a major step in the development of SB623 for stroke patients. Planning for the next phase of testing is already underway." said Keita Mori, SanBio CEO.

SB623 is being delivered to the damaged region of the brains of patients who have suffered an ischemic stroke.  Product safety is the primary focus of the study but various measurements of efficacy are also being tested.

"Stroke is the major cause of disability in the United States. Regenerative medicine offers hope to those with otherwise permanent functional limitations. This trial represents an important advance in bringing restorative therapeutics for neurologic disorders into the clinical arena. Three measures of efficacy (NIHSS, ESS, Fugl-Meyer) all show a trend toward improvement.  We are looking forward to the next clinical trial," said Dr. Gary K. Steinberg, M.D., Ph.D., Bernard and Ronni Lacroute-William Randolph Hearst Professor of Neurosurgery and the Neurosciences, Director, St
'/>"/>

SOURCE SanBio Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients with Traumatic Brain Injury
2. Ryan & Maniskas, LLP Announces Class Action Lawsuit Against NuVasive, Inc.
3. Hamilton Regional Laboratory Medicine Program Announces Decision to Acquire COPANs WASPLab, the Next Generation Full Laboratory Automation and Digital Bacteriology System
4. IVD Technology Magazine Announces the IVD Business Strategy Conference in San Diego
5. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
6. Intra-Cellular Therapies Announces Closing of $60 Million Private Placement and Completion of Reverse Merger
7. Encision Announces Death of Chief Executive Officer Fred F. Perner
8. Sanomedics Announces Completion of Prime Time Medical Acquisition
9. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
10. Halozyme Announces Roche Receives Marketing Authorization for Herceptin SC in European Union
11. Neurotrope, Inc., Announces Reverse Merger and Completion of $21.9 Million Private Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Vermillion, Inc. (NASDAQ: VRML), a ... will hold a conference call on Thursday, August 14, 2014, ... second quarter ended June 30, 2014. Financial results will be ... Vermillion,s Chairman, President and CEO James LaFrance ... period. Date: Thursday, August 14, 2014 Time: 4:30 ...
(Date:7/31/2014)... 2014 TB Alliance, a not-for-profit with ... and affordable treatments, announced the appointment of ... Affairs. Mr. Brock comes to TB Alliance having ... Relations for WWF International (formerly known as the ... will guide the TB Alliance,s resource development, advocacy ...
(Date:7/31/2014)... July 31, 2014 Cryoport, Inc. (OTCBB: CYRX) ... ended June 30, 2014. Recent Operating ... million for the three month period ended June 30, ... Partnered with DHL to further expand Cryoport,s global reach ... , Advanced support of Immudex, an immunotherapy and vaccine ...
Breaking Medicine Technology:Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8
... TUSTIN, Calif., Jan. 6, 2012 Radient Pharmaceuticals Corporation ... Vitro Diagnostic (IVD) cancer tests, today announced that ... will be launched with a print ad that ... throughout 2012.  These journals have high circulation among ...
... WAYNE, N.J., Jan. 6, 2012  Cascade Medical ... proprietary platelet-rich plasma (PRP) and platelet-rich fibrin matrix (PRFM) ... tissue and bone repair, announced the sale of their ... ConMed Linvatec for the worldwide orthopedic, dental, and wound ...
Cached Medicine Technology:Radient Pharmaceuticals Announces New Advertisement for Oncology Publications 2Cascade Medical Enterprises, LLC Announces the Sale of Their Orthopedic Business 2
(Date:7/31/2014)... United Theological Seminary will kick off ... September 15, with its 2014 Opening Convocation, to be ... Rd., Kettering, OH. Dr. Emma J. Justes, Distinguished Professor ... Chair will speak on “Unexpected Undercurrents: Responding to Secrets ... research interests include pastoral care and counseling, pastoral theology, ...
(Date:7/31/2014)... 31, 2014 In today’s world, a good ... get. Snoring and sleep apnea (a medical problem where the ... their bed partners of the rest they need to face ... population snores and 20 million people in the United States ... diagnosed and treated; and of those treated, many cannot tolerate ...
(Date:7/31/2014)... Hook Your Ex, a system created by Steve Pratt, who discovered ... their partner, to the point of starvation, that they come back ... taught to hundreds of men and women across the country with ... , Shane Michaels agrees this simple trick is genius and can ... chance at getting back together with their ex. “I was ...
(Date:7/31/2014)... July 31, 2014 NEWwoodworks, fine woodworking ... expanding their brand presence with a website dedicated to ... years, NEWwoodworks has specialized in handcrafted cabinetry, furniture, ... NEWwoodworks has earned a reputation for taking on the ... on. They commonly craft with reclaimed wood, often using ...
(Date:7/31/2014)... Dr. Mohebi was asked about his experience ... of traveling and sharing what we learned through research ... We are now witnessing results that we never thought ... pleasure to communicate this knowledge to our international colleagues.” ... performing FUE transplantation helped inspire many other doctors to ...
Breaking Medicine News(10 mins):Health News:United Theological Seminary to Open 144th Year 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Hook Your Ex Review by Shane Michaels Exposes Steve Pratt And His New Method For Getting Back With The Ex 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 3Health News:Los Angles Hair Transplant Surgeon, Dr. Parsa Mohebi Inspires Doctors at Global Conferences to Adopt His Novel Method in FUE Hair Transplantation 2
... ANGELES, April 24 SEIU United Healthcare,Workers - West ... have reached a tentative agreement on a new five-year ... more than 570,healthcare workers at MPTF Hospital and Health ... by the SEIU UHW,bargaining committee to its membership, and ...
... cancers that depend on hormones and those that ... 25th in the open-access journal PLoS Genetics. , ... which usually require treatment with surgery and anti-hormone ... hormone independent breast cancers, which are treated with ...
... high-quality care at best cost, study says , , THURSDAY, ... privately insured patients in the United States are being ... is due to physicians who refer patients to their ... find. , For the study, Dr. Jean M. Mitchell, ...
... But survey finds many aren,t prepared to tackle the ... News) -- While most public health department officials in ... warming seriously, the majority say they aren,t prepared to ... percent of local health department directors said they believed ...
... April 24 The U.S. Senate voted,95 to ... ("GINA," H.R.,493), which bars employers and health insurers ... own or their family members, genetic,information, on April ... and Communications at,the U.S. Conference of Catholic Bishops, ...
... for 21st,Century Medicine (http://www.twentyfirstcenturymedicine.org ), a ... diagnostic technology,companies, clinical laboratories, venture capitalists, and ... the passage of the Genetic,Information Nondiscrimination Act ... The House of Representatives passed GINA ...
Cached Medicine News:Health News:Settlement Reached Between Motion Picture & Television Fund and SEIU UHW 2Health News:Increase in Diagnostic Imaging Fueled by Self-Referring Doctors 2Health News:Local Health Officials Recognize Threat of Global Warming 2Health News:Local Health Officials Recognize Threat of Global Warming 3Health News:Coalition for 21st Century Medicine Congratulates U.S. Senate on Passage of Genetic Information Nondiscrimination Act 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: